Reverse Osmosis (RO) Antiscalant Market Report 2026

The reverse osmosis (RO) antiscalant market size has grown strongly in recent years. It will grow from $4.01 billion in 2025 to $4.22 billion in 2026 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to increasing use of RO systems, rising scaling issues in water treatment, adoption of phosphorus-based antiscalants, growth of municipal and industrial water infrastructure, demand for higher membrane lifespan.

The reverse osmosis (RO) antiscalant market size is expected to see strong growth in the next few years. It will grow to $5.22 billion by 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to growing adoption of synthetic polymeric and natural green antiscalants, expansion of seawater desalination projects, increasing industrial water treatment applications, rising focus on environmental compliance, development of advanced antiscalant formulations for complex water chemistries. Major trends in the forecast period include increasing adoption of green and biodegradable antiscalants, rising demand for liquid antiscalant formulations, growing integration of ro antiscalants in industrial water treatment, expansion of antiscalant use in seawater desalination plants, rising focus on scale prevention in pharmaceutical and food & beverage water systems.

The expansion of the pharmaceutical and biotech sectors is expected to propel the growth of the RO antiscalant market going forward. The pharmaceutical and biotech sectors encompass companies engaged in drug discovery, development, manufacturing, and biologics production. The pharmaceutical and biotech sectors are expanding primarily due to rising R&D investments, as organizations intensify their efforts to develop innovative drugs and biologics, thereby contributing to overall sector advancement. RO antiscalants are utilized in these sectors to prevent scaling in reverse osmosis systems that generate ultra-pure water for formulation, equipment cleaning, and processing, thereby supporting consistent water quality, safeguarding membrane integrity, and maintaining operational efficiency. For instance, in October 2025, according to official UK government statistics, life sciences manufacturing turnover reached $61.57 billion (£46.5 billion) in 2023-2024, accounting for 32% of total sector turnover. Therefore, the expansion of the pharmaceutical and biotech sectors is driving the growth of the RO antiscalant market.

Companies operating in the RO antiscalant market are focusing on developing advanced solutions such as smart antiscalant dosing systems to enhance efficiency and reduce chemical and energy consumption. Smart antiscalant dosing systems utilize real-time data analytics and automated controls to adjust chemical dosing based on water quality and operational conditions, thereby minimizing waste and optimizing system performance. In 2025, Grundfos, a Denmark-based company, implemented its Smart Filtration Suite featuring the SmartRO algorithm at a desalination plant in Vadodara, India. The system autonomously determines optimal dosing levels through integrated data analytics, an antiscalant controller, and an optimization module operating in automated mode. This solution reduced energy consumption by 7% and chemical usage by 68%, while also lowering pump energy requirements, demonstrating significant improvements in operational efficiency.

In February 2025, Solenis, a US-based provider of specialty chemicals and water treatment solutions, acquired NCH Corporation for an undisclosed amount. With this acquisition, Solenis intends to broaden its global presence, enhance its technological capabilities, and diversify its portfolio across industrial and water treatment applications. NCH Corporation is a US-based company that provides reverse osmosis (RO) antiscalants through its water treatment division.

Major companies operating in the reverse osmosis (RO) antiscalant market are BASF SE, Dow Chemicals, Ecolab Inc., Veolia, SNF Floerger, Gradiant, DuPont, Kurita Water Industries Ltd., Univar Solutions LLC, Kemira Oyg, Genoasis, Genesys International Ltd., Avista Membrane Solutions, Solenis, Shandong IRO Water Treatment Co., Ltd., ACURO ORGANICS LIMITED, Jayem Engineers, GreenFission Chemicals Private Limited, Radik Chemicals, BioKrishi Technologies Pvt. Ltd., Candour Water Solutions'

Asia-Pacific was the largest region in the reverse osmosis (RO) antiscalant market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the reverse osmosis (RO) antiscalant market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the reverse osmosis (RO) antiscalant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The reverse osmosis (RO) Antiscalant market consists of sales of organophosphonate antiscalants, polyacrylate antiscalants, sulfonated copolymer antiscalants, silica control antiscalants, sulfate scale inhibitors, carbonate scale inhibitors, liquid RO antiscalant solutions, and concentrated RO antiscalant formulations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.